Skip to main content
RVPH logo

RVPH · Reviva Pharmaceuticals Holdings, Inc. · Executive Compensation

Track RVPH — free
$0.39 +0.04 (+10.76%) At close · May 14
Market Cap
$6.33M
Shares
13.11M
Volume · May 14 742.02K Avg daily vol (48 sessions) 985.8K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024
Executive Total
Laxminarayan Bhat $607,500
Narayan Prabhu $404,950
Fiscal 2023
Executive Total
Laxminarayan Bhat $2,764,747
Narayan Prabhu $1,248,778
Fiscal 2022
Executive Total
Laxminarayan Bhat $560,000
Narayan Prabhu $412,500
Marc Cantillon $348,587
Fiscal 2021
Executive Total
Laxminarayan Bhat $600,054
Marc Cantillon $501,981
Narayan Prabhu $437,134
Fiscal 2020
Executive Total
Laxminarayan Bhat $247,952
Marc Cantillon $46,042
Narayan Prabhu $45,304
Fiscal 2019
Executive Total
Laxminarayan Bhat $240,000
Narayan Prabhu —
Marc Cantillon —
Key facts CIK 1742927 CUSIP 76152G209 13F (30d) 1 filings 1 filers Visit website Investor relations